Effects of growing-up milk supplemented with prebiotics and LCPUFAs on infections in young children

J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):428-37. doi: 10.1097/MPG.0000000000000252.

Abstract

Objective: The aim of this study was to investigate the effect of growing-up milk (GUM) with added short-chain galacto-oligosaccharides (scGOS)/long-chain fructo-oligosaccharides (lcFOS) (9:1) (Immunofortis) and n-3 long-chain polyunsaturated fatty acids (LCPUFAs) on the occurrence of infections in healthy children attending day care centres.

Methods: In a randomised double-blind controlled, parallel, multicountry intervention study, 767 healthy children, ages 11 to 29 months, received GUM with scGOS/lcFOS/LCPUFAs (the active group, n = 388), GUM without scGOS/lcFOS/LCPUFAs (the control group, n = 379), or cow's milk (n = 37) for 52 weeks. The primary outcome measure was the number of episodes of upper respiratory tract infections or gastrointestinal infections based on a combination of subject's illness symptoms reported by the parents during the intervention period.

Results: Children in the active group compared with the control group had a decreased risk of developing at least 1 infection (299/388 [77%] vs 313/379 [83%], respectively, relative risk 0.93, 95% confidence interval [CI] 0.87-1.00; logistic regression P = 0.03). There was a trend toward a reduction (P = 0.07) in the total number of infections in the active group, which was significant when confirmed by one of the investigators (268/388 [69%] vs 293/379 [77%], respectively, relative risk 0.89, 95% CI 0.82-0.97; P = 0.004, post hoc). More infectious episodes were observed in the cow's milk group, when compared with both GUM groups (34/37 [92%] vs 612/767 [80%], respectively, relative risk 1.15, 95% CI 1.04-1.28).

Conclusions: This is the first study in children to show a reduced risk of infection following consumption of GUM supplemented with scGOS/lcFOS/n-3 LCPUFAs. The borderline statistical significance justifies a new study to confirm this finding.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Body Height
  • Body Mass Index
  • Body Weight
  • Child, Preschool
  • Diarrhea / epidemiology
  • Diarrhea / microbiology
  • Dietary Supplements
  • Double-Blind Method
  • Fatty Acids, Omega-3 / administration & dosage*
  • Female
  • Fever / epidemiology
  • Fever / microbiology
  • Fructose
  • Galactose
  • Humans
  • Infant
  • Infections / epidemiology*
  • Male
  • Milk*
  • Oligosaccharides / administration & dosage*
  • Prebiotics*
  • Respiratory Tract Infections / epidemiology
  • Vomiting / epidemiology
  • Vomiting / microbiology

Substances

  • Fatty Acids, Omega-3
  • Oligosaccharides
  • Prebiotics
  • Fructose
  • Galactose